CureSeq

CureSeq is an oncogenomics company revolutionizing the treatment of cancer with its precision medicine platform. Our innovative next generation sequencing and bioinformatics technologies transform cancer treatment by rapidly and accurately identifying targeted therapies for patients. Our precision medicine applications and rapid three-day turnaround empower oncologists to select the optimal treatment regimen. The company also enables development of new cancer therapies with novel technologies for drug developers and oncology researchers. CureSeq is committed to continuing to commercialize products to advance the understanding and treatment of cancer throughout the globe.